Physician
Wenatchee Valley Hospital
Wenatchee Valley Hospital was paid $22.82M by Medicaid between Jan 2018 and Jun 2023, across 359 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 49% of everything it billed.
33Billing provider infoWENATCHEE VALLEY HOSPITAL
WENATCHEE, WA 98801
WENATCHEE, WA 98801
33aNPI1295071520assigned 12/13/2012
33bProvider typeEmergency Medical Services (Emergency Medicine) Physician
28Total paid$22.82M
24GClaims599,304
24DCodes billed359
24AFirst – last monthJan 2018 – Jun 2023
Compared with peers
Next to other Emergency Medical Services (Emergency Medicine) Physician providers in Washington
Rank by total paid#1 of 8
Median peer was paid$265K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ADAMS, GLENN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 139,279 | $4.69M | |
| 2019 | 73,765 | $3.11M | |
| 2020 | 70,888 | $2.50M | |
| 2021 | 107,035 | $3.89M | |
| 2022 | 137,509 | $5.68M | |
| 2023 | 70,828 | $2.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 49% | 136,454 | 116,416 | $11.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.9% | 11,084 | 10,348 | $1.34M |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.3% | 2,410 | 2,174 | $764K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2.6% | 1,752 | 1,710 | $602K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.3% | 6,575 | 6,158 | $524K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.1% | 1,657 | 1,607 | $471K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.7% | 1,437 | 1,398 | $378K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 625 | 620 | $354K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 2,298 | 2,242 | $339K |
| 52000 | 1.4% | 828 | 795 | $323K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 3,332 | 3,218 | $294K |
| 20610 | 1.3% | 2,190 | 2,020 | $292K |
347 more codes
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.3% | 165 | $290K |
| 92550 | 1.2% | 1,773 | $268K | |
| 92587 | 1.0% | 1,407 | $233K | |
| 95886 | <1% | 1,630 | $217K | |
| 17110 | <1% | 948 | $203K | |
| 92551 | <1% | 3,891 | $198K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,564 | $193K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 359 | $189K |
| 92567 | <1% | 4,593 | $188K | |
| 95117 | <1% | 7,163 | $158K | |
| 11102 | <1% | 687 | $152K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 913 | $149K |
| 31575 | <1% | 749 | $146K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 440 | $139K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,213 | $120K |
| 64615 | <1% | 654 | $110K | |
| 92557 | <1% | 2,307 | $105K | |
| 29075 | <1% | 370 | $103K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,195 | $100K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 673 | $97K |
| 17000 | <1% | 906 | $96K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 610 | $92K |
| 11100 | <1% | 318 | $90K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 455 | $77K |
| 92552 | <1% | 931 | $72K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 674 | $71K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,602 | $66K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 337 | $61K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,226 | $52K |
| 95115 | <1% | 2,371 | $52K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 25,428 | $49K |
| 11900 | <1% | 239 | $49K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 379 | $48K |
| 11104 | <1% | 143 | $47K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,594 | $46K |
| 31231 | <1% | 274 | $44K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 483 | $43K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,935 | $42K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 124 | $40K |
| G0008 | Administration of influenza virus vaccine | <1% | 2,969 | $38K |
| 11750 | <1% | 121 | $37K | |
| 43235 | <1% | 96 | $37K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 1,426 | $31K |
| 0072A | <1% | 727 | $30K | |
| 0071A | <1% | 634 | $26K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 815 | $25K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 74 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,454 | $25K |
| 43248 | <1% | 53 | $24K | |
| 87428 | <1% | 6,558 | $24K | |
| 92555 | <1% | 1,147 | $24K | |
| 20550 | <1% | 151 | $24K | |
| 71250 | <1% | 384 | $23K | |
| 69210 | <1% | 794 | $22K | |
| 80047 | <1% | 5,029 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,434 | $21K |
| 92579 | <1% | 1,150 | $20K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,995 | $19K |
| 71271 | <1% | 347 | $18K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,570 | $18K |
| 59025 | Fetal non-stress test | <1% | 103 | $18K |
| 95908 | <1% | 323 | $18K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 262 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,142 | $17K |
| 29065 | <1% | 45 | $16K | |
| 42826 | <1% | 12 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,209 | $15K |
| 58300 | <1% | 142 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,280 | $15K |
| 92586 | <1% | 70 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 6,567 | $14K |
| 80305 | <1% | 2,650 | $14K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,951 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 407 | $14K |
| 80050 | General health panel | <1% | 1,931 | $13K |
| 81025 | <1% | 7,445 | $13K | |
| 80061 | Lipid panel | <1% | 3,384 | $13K |
| 85610 | <1% | 12,458 | $11K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,705 | $11K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 187 | $11K |
| 92504 | <1% | 286 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 54 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,144 | $10K |
| 93017 | <1% | 114 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,221 | $10K |
| 95885 | <1% | 58 | $9K | |
| C9257 | Injection, bevacizumab, 0.25 mg | <1% | 163 | $9K |
| 81003 | <1% | 6,504 | $9K | |
| 95910 | <1% | 261 | $9K | |
| 76830 | Ultrasound, transvaginal | <1% | 114 | $9K |
| 73630 | <1% | 2,025 | $9K | |
| 86140 | <1% | 3,044 | $9K | |
| 80076 | <1% | 3,574 | $9K | |
| 90715 | <1% | 896 | $8K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 129 | $8K |
| 93976 | <1% | 154 | $8K | |
| 84439 | <1% | 949 | $8K | |
| 93971 | <1% | 88 | $8K | |
| 99285 | Emergency room visit (most serious) | <1% | 66 | $8K |
| 88142 | <1% | 533 | $8K | |
| 87081 | <1% | 1,829 | $8K | |
| 84403 | <1% | 528 | $8K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 136 | $8K |
| 84484 | <1% | 1,529 | $8K | |
| 86780 | <1% | 629 | $7K | |
| 92083 | <1% | 183 | $7K | |
| 73110 | <1% | 1,907 | $7K | |
| 93226 | <1% | 225 | $7K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 27 | $7K |
| 82570 | <1% | 1,714 | $7K | |
| 73564 | <1% | 1,683 | $7K | |
| 73140 | <1% | 1,611 | $6K | |
| 87653 | <1% | 424 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 40 | $6K |
| 82728 | <1% | 1,359 | $6K | |
| 82607 | <1% | 875 | $6K | |
| 87077 | <1% | 3,264 | $6K | |
| 73610 | <1% | 1,696 | $6K | |
| 86580 | <1% | 713 | $5K | |
| 97803 | <1% | 139 | $5K | |
| 11055 | <1% | 63 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 28 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,010 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,179 | $5K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 14 | $5K |
| 83605 | <1% | 963 | $5K | |
| 87210 | <1% | 1,159 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,113 | $5K |
| 95909 | <1% | 82 | $5K | |
| 81002 | <1% | 5,811 | $4K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 78 | $4K |
| 73030 | <1% | 1,132 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 865 | $4K |
| 70486 | <1% | 48 | $4K | |
| 85652 | <1% | 2,442 | $4K | |
| 90686 | <1% | 2,859 | $4K | |
| 88342 | <1% | 948 | $4K | |
| 83540 | <1% | 970 | $4K | |
| 90671 | <1% | 299 | $4K | |
| 92585 | <1% | 12 | $4K | |
| 86706 | <1% | 641 | $4K | |
| 86431 | <1% | 803 | $4K | |
| 84270 | <1% | 341 | $4K | |
| J3490 | Unclassified drugs | <1% | 5,540 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 462 | $3K |
| 85007 | <1% | 737 | $3K | |
| 87070 | <1% | 1,660 | $3K | |
| 85027 | <1% | 1,340 | $3K | |
| 73130 | <1% | 1,047 | $3K | |
| 51798 | <1% | 2,313 | $3K | |
| 81001 | <1% | 7,096 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,581 | $3K |
| 90670 | <1% | 1,389 | $3K | |
| 95911 | <1% | 132 | $3K | |
| 80074 | <1% | 458 | $3K | |
| 0124A | <1% | 89 | $3K | |
| 58301 | <1% | 26 | $3K | |
| 72100 | <1% | 309 | $3K | |
| 87040 | <1% | 429 | $3K | |
| 82043 | <1% | 1,566 | $2K | |
| 85379 | <1% | 546 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 311 | $2K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 763 | $2K |
| 84481 | <1% | 414 | $2K | |
| 83970 | <1% | 265 | $2K | |
| 0074A | <1% | 53 | $2K | |
| 0054A | <1% | 57 | $2K | |
| 86703 | <1% | 391 | $2K | |
| 83690 | <1% | 3,008 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,296 | $2K |
| 73502 | <1% | 569 | $2K | |
| 83735 | <1% | 1,043 | $2K | |
| 17003 | <1% | 475 | $2K | |
| 73070 | <1% | 469 | $2K | |
| 92650 | <1% | 15 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,433 | $2K |
| 86677 | <1% | 165 | $2K | |
| 82962 | <1% | 3,772 | $2K | |
| 82784 | <1% | 159 | $1K | |
| 84153 | <1% | 350 | $1K | |
| 58100 | <1% | 13 | $1K | |
| 95819 | <1% | 12 | $1K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 4,811 | $1K |
| 73100 | <1% | 418 | $1K | |
| 87147 | <1% | 486 | $1K | |
| 93296 | <1% | 188 | $1K | |
| 90651 | <1% | 981 | $1K | |
| 84146 | <1% | 98 | $1K | |
| 87563 | <1% | 148 | $1K | |
| 83001 | <1% | 81 | $1K | |
| 81015 | <1% | 480 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 95 | $1K |
| 86850 | <1% | 381 | $1K | |
| 86038 | <1% | 198 | $1K | |
| 51702 | <1% | 108 | $1K | |
| 86900 | <1% | 313 | $1K | |
| 95024 | <1% | 145 | $1K | |
| 82247 | <1% | 115 | $1K | |
| 0154A | <1% | 23 | $986.60 | |
| 97802 | <1% | 14 | $976.57 | |
| 97597 | <1% | 32 | $961.26 | |
| 11720 | <1% | 78 | $903.84 | |
| 92134 | <1% | 1,388 | $863.74 | |
| 36416 | <1% | 4,604 | $825.93 | |
| 83880 | <1% | 183 | $804.84 | |
| 86762 | <1% | 232 | $801.81 | |
| 72040 | <1% | 310 | $784.50 | |
| 76942 | <1% | 13 | $755.39 | |
| 87340 | <1% | 299 | $734.81 | |
| 90688 | <1% | 50 | $724.65 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 148 | $714.15 |
| 87186 | <1% | 812 | $709.64 | |
| 92136 | <1% | 27 | $704.11 | |
| 87807 | <1% | 329 | $693.84 | |
| 82248 | <1% | 161 | $688.78 | |
| 73562 | <1% | 134 | $639.88 | |
| 85014 | <1% | 133 | $624.67 | |
| 73590 | <1% | 82 | $613.01 | |
| 86803 | <1% | 175 | $597.49 | |
| 82670 | <1% | 42 | $589.66 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 2,701 | $575.37 |
| 82746 | <1% | 208 | $575.36 | |
| 87045 | <1% | 98 | $575.15 | |
| 0081A | <1% | 13 | $543.80 | |
| 82565 | <1% | 134 | $520.84 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 80 | $516.42 |
| 87899 | <1% | 171 | $511.45 | |
| 0082A | <1% | 12 | $503.80 | |
| 84100 | <1% | 405 | $502.55 | |
| 86901 | <1% | 313 | $502.15 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,762 | $492.21 |
| 82627 | <1% | 24 | $436.53 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 11,269 | $433.26 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 65 | $411.43 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,335 | $393.74 |
| 82550 | <1% | 75 | $390.11 | |
| 11721 | <1% | 25 | $373.05 | |
| 82533 | <1% | 25 | $370.33 | |
| 87640 | <1% | 26 | $363.62 | |
| 83721 | <1% | 126 | $359.85 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12,370 | $353.70 |
| 80178 | <1% | 41 | $350.71 | |
| 93225 | <1% | 13 | $335.98 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 264 | $333.73 |
| 73560 | <1% | 144 | $326.65 | |
| 84702 | <1% | 41 | $308.26 | |
| 82947 | <1% | 348 | $306.52 | |
| 85018 | <1% | 131 | $303.95 | |
| 83002 | <1% | 28 | $299.78 | |
| 84550 | <1% | 169 | $296.39 | |
| 51705 | <1% | 14 | $293.88 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,492 | $284.57 |
| 73600 | <1% | 97 | $272.98 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,539 | $264.38 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,174 | $256.73 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 882 | $240.16 |
| 80164 | <1% | 39 | $230.71 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 7,680 | $230.37 |
| 96376 | <1% | 300 | $212.16 | |
| 74018 | <1% | 140 | $193.05 | |
| 93299 | <1% | 13 | $191.75 | |
| 92133 | <1% | 452 | $158.06 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 732 | $150.07 |
| 90620 | <1% | 155 | $146.24 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 101 | $142.77 |
| 84156 | <1% | 40 | $142.39 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,749 | $140.18 |
| 84460 | <1% | 93 | $139.50 | |
| J2704 | Injection, propofol, 10 mg | <1% | 6,658 | $137.08 |
| 84703 | <1% | 26 | $112.73 | |
| 82150 | <1% | 15 | $112.35 | |
| 83516 | <1% | 22 | $110.10 | |
| 30901 | <1% | 13 | $102.36 | |
| 86308 | <1% | 12 | $93.91 | |
| 88304 | <1% | 189 | $90.70 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 827 | $80.85 |
| 90648 | <1% | 269 | $80.56 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,515 | $79.49 |
| 82340 | <1% | 12 | $78.30 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 380 | $71.22 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 15 | $62.87 |
| 88112 | <1% | 27 | $62.48 | |
| 73090 | <1% | 83 | $60.48 | |
| 73000 | <1% | 37 | $55.24 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 46 | $46.39 |
| 87493 | <1% | 12 | $44.33 | |
| 11730 | <1% | 12 | $44.06 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 13 | $41.08 |
| 94760 | <1% | 149 | $39.78 | |
| 90707 | <1% | 407 | $31.55 | |
| 87205 | <1% | 333 | $31.20 | |
| 82274 | <1% | 14 | $30.67 | |
| 99173 | <1% | 3,877 | $30.03 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 400 | $29.25 |
| J7999 | Compounded drug, not otherwise classified | <1% | 162 | $22.48 |
| 92582 | <1% | 44 | $20.29 | |
| 86705 | <1% | 12 | $16.89 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 777 | $10.50 |
| 88341 | <1% | 69 | $10.15 | |
| 82803 | <1% | 38 | $8.12 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 379 | $5.85 |
| 90734 | <1% | 459 | $0.02 | |
| 90633 | <1% | 942 | $0.01 | |
| 90672 | <1% | 145 | $0.01 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 77 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 950 | $0.00 |
| 90710 | 0% | 384 | $0.00 | |
| 87075 | 0% | 155 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 732 | $0.00 |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | 0% | 172 | $0.00 |
| 99152 | 0% | 143 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 211 | $0.00 |
| 90700 | 0% | 152 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 341 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 28 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 28 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 630 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 108 | $0.00 |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | 0% | 170 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 26 | $0.00 |
| 88312 | 0% | 96 | $0.00 | |
| 51741 | 0% | 40 | $0.00 | |
| 94664 | 0% | 24 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 18 | $0.00 |
| C1758 | Catheter, ureteral | 0% | 13 | $0.00 |
| A4550 | Surgical trays | 0% | 103 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 12 | $0.00 |
| 90473 | 0% | 16 | $0.00 | |
| 90716 | 0% | 450 | $0.00 | |
| 90474 | 0% | 1,187 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 3,481 | $0.00 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 0% | 227 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 122 | $0.00 |
| 90696 | 0% | 362 | $0.00 | |
| 90619 | 0% | 317 | $0.00 | |
| 90698 | 0% | 218 | $0.00 | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 0% | 13 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 669 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 126 | $0.00 |
| 90680 | 0% | 1,242 | $0.00 | |
| 90697 | 0% | 1,104 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 140 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 13 | $0.00 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 0% | 18 | $0.00 |
| Q4008 | Cast supplies, long arm cast, pediatric (0-10 years), fiberglass | 0% | 14 | $0.00 |
| 90723 | 0% | 79 | $0.00 | |
| C1769 | Guide wire | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialADAMS, GLENN (COO)
| Provider | Location | Paid |
|---|---|---|
| Wenatchee Valley Hospital | Wenatchee, WA | $19.53M |
| Wenatchee Valley Hospital | Wenatchee, WA | $14.05M |
| Wenatchee Valley Hospital | Moses Lake, WA | $8.59M |
| Wenatchee Valley Hospital | East Wenatchee, WA | $7.41M |
| Wenatchee Valley Hospital | Omak, WA | $5.62M |
| Keystone Medical Services of Gulfport, INC. | Gulfport, MS | $4.53M |
| Keystone Medical Services of MS, INC | Hazlehurst, MS | $4.11M |
| Wenatchee Valley Hospital | Wenatchee, WA | $2.42M |
| Medical Services of Meridian, INC. | Memphis, TN | $2.10M |
| Wenatchee Valley Hospital | Tonasket, WA | $1.18M |
| Wenatchee Valley Hospital | Cashmere, WA | $610K |
| Wenatchee Valley Hospital | Oroville, WA | $448K |
| Keystone Medical Services of Alabama, INC. | Troy, AL | $440K |
| Wenatchee Valley Hospital | Brewster, WA | $420K |
| Wenatchee Valley Hospital | Royal City, WA | $395K |
| Wenatchee Valley Hospital | Ephrata, WA | $394K |
| Wenatchee Valley Hospital | Wenatchee, WA | $357K |
| Keystone Hospitalist Services of MS INC | Tylertown, MS | $268K |
| Wenatchee Valley Hospital | Waterville, WA | $231K |
| Keystone Medical Services of Ferriday, INC. | Ferriday, LA | $227K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.